Search by Drug Name or NDC

    NDC 65649-0003-03 Trulance 3 mg/1 Details

    Trulance 3 mg/1

    Trulance is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Salix Pharmaceuticals Inc.. The primary component is PLECANATIDE.

    Product Information

    NDC 65649-0003
    Product ID 65649-003_e757981c-c4fc-4702-83ee-0d90382fb959
    Associated GPIs 52543060000320
    GCN Sequence Number 077047
    GCN Sequence Number Description plecanatide TABLET 3 MG ORAL
    HIC3 D6G
    HIC3 Description IBS-C/CIC AGENTS, GUANYLATE CYCLASE-C AGONIST
    GCN 42925
    HICL Sequence Number 044054
    HICL Sequence Number Description PLECANATIDE
    Brand/Generic Brand
    Proprietary Name Trulance
    Proprietary Name Suffix Immediate release
    Non-Proprietary Name Plecanatide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 3
    Active Ingredient Units mg/1
    Substance Name PLECANATIDE
    Labeler Name Salix Pharmaceuticals Inc.
    Pharmaceutical Class Guanylate Cyclase Activators [MoA], Guanylate Cyclase-C Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208745
    Listing Certified Through 2024-12-31

    Package

    NDC 65649-0003-03 (65649000303)

    NDC Package Code 65649-003-03
    Billing NDC 65649000303
    Package 1 BOTTLE in 1 CARTON (65649-003-03) / 3 TABLET in 1 BOTTLE
    Marketing Start Date 2017-02-21
    NDC Exclude Flag N
    Pricing Information N/A